News

A new add-on treatment for partial onset seizures, with or without secondary generalised seizures, has been authorised in adults with epilepsy. Brivaracetam (Briviact) is an anti-epileptic drug that provides patients, with this particular…

The results of a new lung cancer trial have demonstrated that afatinib is superior in reducing the risk of lung cancer progression to gefitinib.

NICE has issued Technology Appraisal Guidance (TAG) for olaparib (Lynparza) for treatment of high-grade serous ovarian cancer.

Results from a new clinical trial show that the use of a specialised nutritional supplement drink was associated with a 50% lower death rate in older malnourished patients with a heart or lung disease 90 days following hospitalisation.

An investigation from the Alzheimer's Society has found that many people with dementia are falling while in hospital, being discharged at night or being marooned in hospital despite their medical treatment having finished.

One in four adults (26%) surveyed as part of the Health Survey for England (HSE) said they had been diagnosed with a mental illness at some point in their lifetime according to the Health and Social Care Information Centre (HSCIC).

Genetic mutations in blood cells that could develop into leukaemia become "almost inevitable" as people get older, new research suggest

NHS England plans to add more diabetes incentives to the GP contract, as part of a new push for earlier diagnosis and treatment of the condition, according to Pulse.

NICE has issued a Final Appraisal Determination (FAD) for the first-in-class type 2 diabetes drug dapagliflozin (Forxiga).

NICE's decision to recommend Eylea as an additional treatment option for those with wet AMD has been welcomed by the optical community.

New research presented recently at the European Congress on Obesity in Liverpool, found that dieters using XLS-Medical Fat Binder (Litramine) were more successful at maintaining weight loss over a 24 week period compared to dieting alone.

Despite previous studies touting its benefit in moderating gout risk, new research reveals that vitamin C, also known ascorbic acid, does not reduce uric acid (urate) levels to a clinically significant degree in patients with established…

Linaclotide (Constella) is now available for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation (IBS-C) in adults.

The European Union of Geriatric Medicine (EUGMS) and Abbott have hosted the first-of-its-kind geriatric nutrition event in the UK.

Hormone replacement therapy (HRT) significantly improves muscle function - down to the muscle fibre level - in postmenopausal women.